Coronavirus vaccine news highlights: Dr Reddy’s submits Phase-II safety data of Sputnik V to DCGI, seeks approval for Phase-III trials
The Centre has signed a purchase order with Pune-based vaccine producer Serum Institute of India for 11 million doses of the Oxford/AstraZeneca Covid-19 vaccine. The vaccine would be available at the price of Rs 200 per dose according to Serum Institute of India (SII) officials. With the Covid-19 vaccination drive in India set to roll out on January 16, SII's Covishield dispatch is likely to be early morning on January 12.